---
title: "Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280997570.md"
description: "Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe"
datetime: "2026-03-30T10:15:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280997570.md)
  - [en](https://longbridge.com/en/news/280997570.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280997570.md)
---

# Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe

Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe

### Related Stocks

- [02696.HK](https://longbridge.com/en/quote/02696.HK.md)

## Related News & Research

- [Henlius Wins Australian Nod for First-in-Class Bispecific Cancer ADC Trial](https://longbridge.com/en/news/286246864.md)
- [08:03 ETNCCN reafirma su compromiso con los recursos para el manejo del malestar relacionado con el cáncer](https://longbridge.com/en/news/287060831.md)
- [Transcenta Gains Boost as Inhibrx’s Ozekibart Data and FDA Filing Strengthen Greater China Cancer Franchise](https://longbridge.com/en/news/287168572.md)
- [06:22 ETNiowave Breaks Ground on New $75 Million Production Facility to Advance Targeted Cancer Therapies](https://longbridge.com/en/news/287200194.md)
- [Lupin bets big on India's GLP-1 market & respiratory drugs](https://longbridge.com/en/news/287021542.md)